These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19296398

  • 1. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
    Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ.
    Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
    [Abstract] [Full Text] [Related]

  • 2. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R, Gheorghe L, Becheanu G, Iacob R, Iacob S, Gheorghe C.
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ, Liu YG, Xu L, Fan JG, Zhang H, Ping L, Shi RF.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [Abstract] [Full Text] [Related]

  • 10. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

  • 11. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):80-9. PubMed ID: 17919273
    [Abstract] [Full Text] [Related]

  • 12. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.
    J Hepatol; 2011 Jan 01; 54(1):64-71. PubMed ID: 20932598
    [Abstract] [Full Text] [Related]

  • 13. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec 01; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK.
    J Viral Hepat; 2006 May 01; 13(5):303-10. PubMed ID: 16637860
    [Abstract] [Full Text] [Related]

  • 16. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, Risso D, Lantieri PB, Icardi G, Barreca T, Testa R.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3211-7. PubMed ID: 11095344
    [Abstract] [Full Text] [Related]

  • 17. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A.
    Gastroenterology; 2008 Feb 01; 134(2):432-9. PubMed ID: 18242211
    [Abstract] [Full Text] [Related]

  • 18. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group.
    Gastroenterology; 2006 May 01; 130(6):1636-42. PubMed ID: 16697727
    [Abstract] [Full Text] [Related]

  • 19. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.
    Hepatogastroenterology; 1999 May 01; 46(28):2422-5. PubMed ID: 10522010
    [Abstract] [Full Text] [Related]

  • 20. Impact of steatosis on insulin secretion in chronic hepatitis C patients.
    Narita R, Abe S, Tabaru A, Otsuki M.
    Am J Gastroenterol; 2007 Oct 01; 102(10):2173-80. PubMed ID: 17680843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.